Your browser doesn't support javascript.
loading
Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS).
Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A.
Afiliación
  • Hammer H; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland. Electronic address: helly.hammer@insel.ch.
  • Kamber N; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Pistor M; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Diem L; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Friedli C; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Chan A; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Hoepner R; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
  • Salmen A; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse, Bern, Switzerland.
Mult Scler Relat Disord ; 65: 104015, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35810719
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Esclerosis Múltiple / Neutropenia Tipo de estudio: Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Esclerosis Múltiple / Neutropenia Tipo de estudio: Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article